Friday, April 17, 2009

Illumina (ILMN) Shares Rise on Analyzing System Sales

Looks like a very nice batch of gene analyzing systems sold by Illumina (ILMN) - I saw this news yesterday but with earnings coming next week, I did not want to add to the position ahead of earnings due to the knee jerk reactions that happen. But it's lit a nice fire under the stock.
  • Shares of genetic analysis company Illumina Inc. rose Thursday after the company said it sold 22 gene analyzing systems to the Broad Institute, boosting that institution's installed base to 47 units. The Broad Institute is a collaboration between Cambridge, Mass., neighbors Massachusetts Institute of Technology and Harvard University. It focuses on genetic research. The Genome Analyzer is one of its main genetic technology products.
  • "The Broad Institute's decision to significantly scale their installed base of Genome Analyzers is a tremendous sign of their confidence in our ability to continue improving the performance and economics of the system," said Illumina Senior Vice President and Chief Financial Officer Christian Henry, in a statement.

  • "Illumina has taken a convincing lead in market share that is unlikely to be challenged meaningfully in the coming quarters," Leerink Swann analyst Issac Ro said in a note to clients.

Long Illumina in fund; no personal position

Disclaimer: The opinions listed on this blog are for educational purpose only. You should do your own research before making any decisions.
This blog, its affiliates, partners or authors are not responsible or liable for any misstatements and/or losses you might sustain from the content provided.

Copyright @2012